NATIONAL CAPITAL LYME DISEASE ASSO… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2001

Legal Domicile

Principal Officer

MONTE L SKALL

Phone

7038218833

Tax Period

2019-01-01 to 2019-12-31

NATIONAL CAPITAL LYME DISEASE ASSOCIATION, founded in 2001, is a small nonprofit in the Diseases & Disorders sector that reported $116K in total revenue in fiscal year 2019. Revenue decreased 9% compared to the prior year. Expenses of $128K exceeded revenue, resulting in a 10% operating deficit.

Mission

THE NATIONAL CAPITAL LYME DISEASE ASSOCIATION STRIVES TO IMPROVE THE QUALITY OF LIFE FOR PEOPLE SUFFERING FROM LYME AND OTHER TICK-BORNE ILLNESSES BY OFFERING SUPPORT AND INFORMATION THAT EDUCATES AND EMPOWERS PATIENTS, FAMILIES AND HEALTH CARE WORKERS, AND THE COMMUNITY AT LARGE ABOUT LYME DISEASE AND ADVOCATING ON THEIR BEHALF.

Program Service Accomplishments

Program 1

Expenses: $9,698 Revenue: $0

LEGISLATIVE EDUCATION AND ADVOCACY: NATIONAL CAPITAL LYME DISEASE ASSOCIATION CREATES AND PARTICIPATES IN ACTIVITIES TO EDUCATE LEGISLATORS TO THE HARMFUL EFFECTS OF LYME DISEASE ON THEIR...

LEGISLATIVE EDUCATION AND ADVOCACY: NATIONAL CAPITAL LYME DISEASE ASSOCIATION CREATES AND PARTICIPATES IN ACTIVITIES TO EDUCATE LEGISLATORS TO THE HARMFUL EFFECTS OF LYME DISEASE ON THEIR CONSTITUENTS AND THE PUBLIC IN GENERAL AND TO ADVOCATE TO LOCAL AND FEDERAL AGENCIES AND LEGISLATIVE BODIES ON THE NEED FOR PROTECTION AND RELIEF FOR THOSE WHO SUFFER FROM THIS EVER-SPREADING DISEASE.

Program 2

Expenses: $46,974 Revenue: $0

PUBLIC INFORMATION AND AWARENESS: NATIONAL CAPITAL LYME DISEASE ASSOCIATION PRINTS BROCHURES AND OTHER DOCUMENTS TO INFORM THE GENERAL PUBLIC, AMONG OTHER THINGS, OF THE DANGERS AND SYMPTOMS OF LYME DISEASE AND HOW TO LIMIT EXPOSURE TO TICKS AND THE PROPER REMOVAL OF TICKS FROM THE BODY.

Program 3

Expenses: $23,500 Revenue: $0

RESEARCH: SUPPORT INNOVATIVE RESEARCH THAT TARGETS THE PATHOGENESIS OF TICKBORNE DISEASES AND TREATMENTS TO IMPROVE OUTCOMES FOR LONG-TERM SEQUELAE OF TICK-BORNE INFECTIONS

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2019)

Revenue Breakdown

Contributions & Grants $115,869

Program Service Revenue $0

Investment Income $13

Other Revenue $0

TOTAL REVENUE $115,882

Expense Breakdown

Grants Paid $46,900

Salaries & Benefits $0

Fundraising Expenses $31,289

Program Expenses $80,172

Other Expenses $81,019

TOTAL EXPENSES $127,919

Year-over-Year Comparison

	2019	2018	Change
Revenue	$115,882	$127,843	-0.1%
Expenses	$127,919	$141,955	-0.1%
Net Income	$-12,037	$-14,112	-0.1%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MONTE L SKALL	EXECTIVE DIRECTOR	80.00	Officer Director	$0	$0	$0
KATHY BOILEAU	DIRECTOR	8.00	Director	$0	$0	$0
NANCY BROOKS	DIRECTOR	5.00	Director	$0	$0	$0
BARBARA COHEN	DIRECTOR	8.00	Director	$0	$0	$0
LISA COLBERT	DIRECTOR	2.00	Director	$0	$0	$0
MAUREEN CRYSTAL	DIRECTOR	2.00	Director	$0	$0	$0
LOUISE FILKINS	DIRECTOR	4.00	Director	$0	$0	$0
VERONICA HOHENSTEIN	DIRECTOR	2.00	Director	$0	$0	$0
MYRA HOLT	DIRECTOR	2.00	Director	$0	$0	$0
JANET JENSEN	DIRECTOR	4.00	Director	$0	$0	$0
JOHN LEE MCLEAN	DIRECTOR	2.00	Director	$0	$0	$0
GEORGE PHILLIPS	DIRECTOR	2.00	Director	$0	$0	$0
PETER ROSENFELD	DIRECTOR	2.00	Director	$0	$0	$0
VERNON TODD	DIRECTOR	4.00	Director	$0	$0	$0
DIANA WATERS	DIRECTOR	2.00	Director	$0	$0	$0
KIM D'ALOISE	DIRECTOR	2.00	Director	$0	$0	$0
ELLEN DOUTY	DIRECTOR	2.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2019	$115,882	$127,919	$434,096	$-12,037
2018	$127,843	$141,955	$446,133	$-14,112

NATIONAL CAPITAL LYME DISEASE ASSOCIATION